Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
Background: Since stroke patients with nonvalvular atrial fibrillation (NVAF) have poor outcomes in general, the prediction of outcomes following discharge is of utmost concern for these patients. We previously reported that brain natriuretic peptide (BNP) levels were significantly higher in NVAF pa...
Κύριοι συγγραφείς: | Kenji Maruyama, Shinichiro Uchiyama, Tsuyoshi Shiga, Mutsumi Iijima, Kentaro Ishizuka, Takao Hoshino, Kazuo Kitagawa |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Karger Publishers
2017-03-01
|
Σειρά: | Cerebrovascular Diseases Extra |
Θέματα: | |
Διαθέσιμο Online: | http://www.karger.com/Article/FullText/457808 |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation
ανά: Tamara Kovačević Preradovic, κ.ά.
Έκδοση: (2023-01-01) -
Nine‐year trend of oral anticoagulant use in patients with embolic stroke due to nonvalvular atrial fibrillation
ανά: Chisa Asahina, κ.ά.
Έκδοση: (2020-10-01) -
One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry
ανά: C.G. Bahuleyan, κ.ά.
Έκδοση: (2021-01-01) -
Prevalence and associated factors of undiagnosed atrial fibrillation among end-stage renal disease patients on maintenance haemodialysis: a cross-sectional study
ανά: Izzat AlAwwa, κ.ά.
Έκδοση: (2020-04-01) -
The reliability and validity of a novel Chinese version simplified modified Rankin scale questionnaire (2011)
ανά: Junliang Yuan, κ.ά.
Έκδοση: (2020-04-01)